Cargando…
Drugs for COVID-19: An Update
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health...
Autores principales: | Ceramella, Jessica, Iacopetta, Domenico, Sinicropi, Maria Stefania, Andreu, Inmaculada, Mariconda, Annaluisa, Saturnino, Carmela, Giuzio, Federica, Longo, Pasquale, Aquaro, Stefano, Catalano, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740261/ https://www.ncbi.nlm.nih.gov/pubmed/36500655 http://dx.doi.org/10.3390/molecules27238562 |
Ejemplares similares
-
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
por: Iacopetta, Domenico, et al.
Publicado: (2022) -
Biological Activities of Ruthenium NHC Complexes: An Update
por: Catalano, Alessia, et al.
Publicado: (2023) -
Triclosan: A Small Molecule with Controversial Roles
por: Sinicropi, Maria Stefania, et al.
Publicado: (2022) -
Synthesis of Novel N-Heterocyclic Carbene-Ruthenium (II) Complexes, “Precious” Tools with Antibacterial, Anticancer and Antioxidant Properties
por: Ceramella, Jessica, et al.
Publicado: (2023) -
Thidiazuron: New Trends and Future Perspectives to Fight Xylella fastidiosa in Olive Trees
por: Catalano, Alessia, et al.
Publicado: (2022)